Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-03-25

Clinical Trial Update: Feasibility Study of AMENUCED Program in Type 2 Diabetes [NA]

View source ↗

Summary

A feasibility study of the AMENUCED program for Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universidad de Sonora | Conditions: Diabete Type 2 | NA | Status: COMPLETED